PolymarketBeschikbaarheid controlerenGeen KYC2% kostenGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige impliciete kans
Ja 87.1%+1.0pt
Marktkwaliteit
74 / 100
Gemiddelde kwaliteit24u volume
€ 15,4K
Liquiditeit
€ 3,9K
Gemiddelde liquiditeitBied / Laat
87.0% / 88.0%
Spread
1.0 pt
Strakke spreadComments
0
Marktdata
Bijgewerkt 14 minuten geleden
19 aug 26, 18:4730 jun 27, 23:59
Trends
Regels
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- Intismeran autogene refers to the individualized neoantigen therapy developed by Moderna and Merck and evaluated in the Phase 3 INTerpath-001 trial (NCT05933577), also known as mRNA-4157 and V940, together with any brand, trade, or nonproprietary name later assigned to that product, as well as any renamed or modified version that the relevant company or the FDA identify as the same product or a direct continuation of the V940/mRNA-4157 program.
- A qualifying application must seek FDA licensure of intismeran autogene through a Biologics License Application (BLA).
- An original BLA or a resubmission of such a BLA following FDA action will qualify.
- The application may cover any indication.
Open markten
Health & Medicine
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+0.1pt4%
- Totaal volume
- € 1,6 mln.
- 24u volume
- € 15K
POLYMARKETHantavirus pandemic in 2026?
- No+0.1pt97%
- Yes-0.1pt3%
- Totaal volume
- € 15,3 mln.
- 24u volume
- € 8,9K
KALSHIMeasles cases in 2026?
- Above 3000-1.0pt96%
- Above 4000-1.0pt81%
- Above 6000+5.0pt29%
+2 extra uitkomsten
- Totaal volume
- € 782,3K
POLYMARKETHeidi Overton confirmed as FDA Commissioner by which date?
- December 3172%
- October 3133%
- November 3033%
+1 extra uitkomsten
- Totaal volume
- € 6,5K
KALSHIWhen will Heidi Overton be confirmed as Commissioner of the FDA?
- Before Aug 1, 202774%
- Before Apr 1, 202767%
- Before Jan 1, 202767%
+2 extra uitkomsten
- Totaal volume
- € 4,5K
- 24u volume
- € 3,7K
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+2.0pt68%
- June 30,-7.5pt24%
- Totaal volume
- € 38,6K
- 24u volume
- € 3,4K
- Will 3 mg THC beverages qualify as hemp under federal law?
- New pandemic in 2026?
- Measles cases in U.S. by August 31?
- How many human screwworm cases will be reported in the United States in 2026?
- Which countries will report an Ebola disease case before October?
- Hantavirus vaccine in 2026?
- Ebola pandemic in 2026?
- FDA decision: Brepocitinib by Priovant Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
Veelgestelde vragen
- Wat zijn de huidige kansen voor Skin cancer vaccine BLA submitted by June 30, 2027??
- Polymarket prijst Yes op 87% per 21 augustus 2026.
- Wanneer wordt Skin cancer vaccine BLA submitted by June 30, 2027? afgewikkeld?
- Skin cancer vaccine BLA submitted by June 30, 2027? wordt naar verwachting op 30 juni 2027 afgewikkeld.
- Hoe wordt Skin cancer vaccine BLA submitted by June 30, 2027? afgewikkeld?
- Polymarket wikkelt deze markt als volgt af: This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.